ArticleJournal of the peripheral nervous system : JPNS2018

A randomised, multi-centre phase III study of 3 different doses of intravenous immunoglobulin 10% in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ProCID trial): Study design and protocol.

David R Cornblath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.